Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

elvitegravir

elvitegravir
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Vitekta TABLET, ORAL 85 mg      
Vitekta TABLET, ORAL 150 mg    
Comments:

ORDER FORMULATION

THERAPEUTIC INTERCHANGE

elvitegravir (Vitekta)

  • 150 mg tablet

elvitegravir (Vitekta)

  • TWO 85 mg tablets (Total: 170 mg)

Reviewed: 25 March 2015 (Vitekta)

Last updated: Dec. 20, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved